New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo
C. Korin Bullen(Johns Hopkins University), Robert F. Siliciano(Howard Hughes Medical Institute), Christine M. Durand(University of Maryland, Baltimore), Janet D. Siliciano(Johns Hopkins University), Gregory M. Laird(Duke Medical Center)
Cited by 498
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia.
|The Journal of Cell Biology|1986|1.6k
Lipidomics reveals a remarkable diversity of lipids in human plasma
|Journal of Lipid Research|2010|1.3k
DNA damage induces phosphorylation of the amino terminus of p53
|Genes & Development|1997|824